Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the ...

Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the ...

Bayer is facing billions of dollars in exposure from a growing number of lawsuits over PCB products. Read more at ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth quarter 2024 investor letter. A ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Inari raised $144 million to bring gene-edited seeds to market and an Israel-based startup looks to develop its computer ...

Bayer (BAYZF) (BAYRY) says elinzanetant, its experimental therapy for hot flashes, reached the main goals in a late-stage ...

By Brendan Pierson and Dietrich Knauth (Reuters) -A Washington jury on Tuesday ordered Bayer to pay $100 million to four ...

It's one of many changes Bayer CEO Bill Anderson has made. Still, the company's stock price this year has struggled.